| Dalaroo Metals Ltd (DAL) ORDINARY FULLY PAID |
Materials |
$21 |
Results of Meeting
|
27 Feb 2026 4:05PM |
$0.066 |
$0.065 |
fallen by
1.52%
|
|
| TechGen Metals Ltd (TG1) ORDINARY FULLY PAID |
Materials |
$20 |
Application for quotation of securities - TG1
|
27 Feb 2026 4:05PM |
$0.052 |
$0.054 |
risen by
3.85%
|
|
| Avecho Biotechnology Limited (AVE) ORDINARY FULLY PAID |
Health Care |
$37 |
Appendix 4G and Corporate Governance Statement
|
27 Feb 2026 4:05PM |
$0.009 |
$0.010 |
risen by
11.11%
|
|
| Kina Securities Limited (KSL) ORDINARY FULLY PAID |
Financials |
$381 |
Update - Dividend/Distribution - KSL
|
27 Feb 2026 4:04PM |
$1.255 |
$1.300 |
risen by
3.59%
|
|
| Avecho Biotechnology Limited (AVE) ORDINARY FULLY PAID |
Health Care |
$37 |
Annual Report 31 December 2025
|
27 Feb 2026 4:04PM |
$0.009 |
$0.010 |
risen by
11.11%
|
|
AVE - Price-sensitive ASX Announcement
Full Release
Key Points
- Consolidated loss before income tax of AUD 4.42 million.
- No income tax expense due to unrecognized deferred tax assets.
- Compensation for key management includes share-based payments.
- Focus on R&D and maintaining a patent portfolio.
- Liquidity and credit risks are managed with sufficient cash balances.
- No dividends were declared for the year.
- Deferred tax assets remain unrecognized.
- Equity incentive plan for employees to promote growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Horizon Oil Limited (HZN) ORDINARY FULLY PAID |
Energy |
$415 |
Ceasing to be a substantial holder
|
27 Feb 2026 4:03PM |
$0.240 |
$0.255 |
risen by
6.25%
|
|
| EZZ Life Science Holdings Limited (EZZ) ORDINARY FULLY PAID |
Health Care |
$60 |
Half Yearly Report and Accounts
|
27 Feb 2026 4:03PM |
$1.525 |
$1.265 |
fallen by
17.05%
|
|
EZZ - Price-sensitive ASX Announcement
Full Release
Key Points
- EZZ Life Science Holdings Limited reported a gross profit of 18.2 million AUD for the half-year ending 31 December 2025.
- The company experienced a loss after income tax of 641,298 AUD for the same period.
- Revenue decreased to 24.8 million AUD from 30.3 million AUD at the end of 2024, due to softer consumer demand in China and increased price competition.
- Sales in Australia and New Zealand increased by 25.8% to 5.4 million AUD.
- EZZ launched three new health supplements during the financial half-year: EZZ Breast Health Capsule, EZZ Women’s Bone Strength Capsule, and EZZ R-21 Ergothioeine Capsule.
- The company maintains a strong cash position of 13.5 million AUD and remains debt-free, allowing for financial flexibility.
- The board decided against a potential merger and acquisition opportunity to prioritize balance sheet strength.
- EZZ continued its partnership with the Australian Open to enhance brand visibility.
- The company incurred non-cash share-based payment expenses of 1.3 million AUD related to Employee Share Schemes.
- Basic earnings per share were reported at negative 1.36 cents.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gryphon Capital Income Trust (GCI) ORDINARY UNITS FULLY PAID |
Financials |
$1,291 |
Net Tangible Asset Backing
|
27 Feb 2026 4:03PM |
$2.040 |
$2.030 |
fallen by
0.49%
|
|
| MaxiPARTS Limited (MXI) ORDINARY FULLY PAID |
Industrials |
$108 |
Change in substantial holding
|
27 Feb 2026 4:01PM |
$1.955 |
$1.940 |
fallen by
0.77%
|
|
| Flagship Minerals Limited (FLG) ORDINARY FULLY PAID |
Materials |
$85 |
Application for quotation of securities - FLG
|
27 Feb 2026 4:00PM |
$0.285 |
$0.270 |
fallen by
5.26%
|
|
| Hubify Limited (HFY) ORDINARY FULLY PAID |
Communication Services |
$11 |
Cleansing notice
|
27 Feb 2026 4:00PM |
$0.021 |
$0.021 |
fallen by
0%
|
|
| Talius Group Limited (TAL) ORDINARY FULLY PAID |
Information Technology |
$24 |
Change of Director's Interest Notice - PH
|
27 Feb 2026 3:53PM |
$0.068 |
$0.069 |
risen by
1.47%
|
|
| AJ Lucas Group Limited (AJL) ORDINARY FULLY PAID |
Industrials |
$12 |
31 December 2025 Results Release
|
27 Feb 2026 3:52PM |
$0.009 |
$0.009 |
fallen by
0%
|
|
| AJ Lucas Group Limited (AJL) ORDINARY FULLY PAID |
Industrials |
$12 |
Appendix 4D and Half Yearly Report
|
27 Feb 2026 3:51PM |
$0.009 |
$0.009 |
fallen by
0%
|
|
AJL - Price-sensitive ASX Announcement
Full Release
Key Points
- AJ Lucas Group Limited reported a net profit after tax of $38.9 million for the half-year ended 31 December 2025, compared to a $11.5 million loss in the previous year.
- The company received a settlement payment of £12.5 million ($25.9 million) related to UK shale gas exploration licences, significantly boosting its financial performance.
- Australian operations faced challenges due to suspended mining operations and a subdued metallurgical coal market, yet reported an EBITDA of $14.1 million, up 37.7% from the previous year.
- Total revenue decreased by 11.8% to $66.9 million, mainly due to challenges in the coal market.
- The company reduced its net liabilities significantly by $39.2 million due to the settlement payout and effective cost management.
- The financial outlook remains positive with ongoing strategies to expand business operations in Australia and potential shale gas developments in the UK.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| RooLife Group Ltd (RLG) ORDINARY FULLY PAID |
Communication Services |
$8 |
Appendix 4D and Half Yearly Financial Statements
|
27 Feb 2026 3:48PM |
$0.004 |
$0.005 |
risen by
12.50%
|
|
RLG - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss for the period was $731,647.
- Revenue from contracts was $3,745,215.
- Equity increased to $3,715,421 with share issuance.
- Significant expenses include product, logistics, and staff costs.
- Issued 285,714,286 shares raising $2,000,000.
- No impairment loss recognized during the period.
- Increased trade and other payables reported.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nutritional Growth Solutions Ltd (NGS) ORDINARY FULLY PAID |
Consumer Staple |
$7 |
Preliminary Final Report
|
27 Feb 2026 3:45PM |
$0.020 |
$0.020 |
fallen by
0%
|
|
NGS - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue declined by 34% to US$1,627.
- Net loss improved to US$1,710 from US$2,899.
- Gross margin fell to 15% from 33%.
- Significant reduction in selling and marketing expenses.
- Raised US$1.7 million through equity and convertible loans.
- End-of-year cash increased to US$517.
- No dividends declared for the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Spookfish Limited (SFI) ORDINARY FULLY PAID |
Information Technology |
- |
Estimated Distribution Announcement
|
27 Feb 2026 3:45PM |
$0.090 |
$0.090 |
fallen by
0%
|
|
| Camplify Holdings Limited (CHL) ORDINARY FULLY PAID |
Industrials |
$28 |
Change of Director's Interest Notice
|
27 Feb 2026 3:45PM |
$0.340 |
$0.340 |
fallen by
0%
|
|
| Cann Group Limited (CAN) ORDINARY FULLY PAID |
Health Care |
$13 |
Cann announces FY25 half year results
|
27 Feb 2026 3:44PM |
$0.008 |
$0.008 |
risen by
6.67%
|
|
| Aerometrex Limited (AMX) ORDINARY FULLY PAID |
Industrials |
$30 |
Correction to Previous ASX Announcement
|
27 Feb 2026 3:44PM |
$0.330 |
$0.315 |
fallen by
4.55%
|
|
| Papyrus Australia Limited (PPY) ORDINARY FULLY PAID |
Materials |
$6 |
Monthly Activities/Appendix 4C Cash Flow Report
|
27 Feb 2026 3:44PM |
$0.010 |
$0.009 |
fallen by
10%
|
|
PPY - Price-sensitive ASX Announcement
Full Release
Key Points
- Papyrus Australia made significant progress in January 2026 with its Rapid Prototyping & R&D Facility in Adelaide and the Australian Commercial Production Facility moving towards commercial readiness.
- The R&D Facility saw all major prototype systems installed and commissioned, enabling early production and product testing.
- The establishment of a plantation-waste supply chain solidified operational readiness.
- Papyrus deepened its collaboration with the University through the Internship Program, benefiting from valuable analytical insights.
- The Australian Commercial Production Facility advanced through procurement and site establishment, with long-lead pulp-preparation equipment ordered.
- Papyrus received the final tranche of $500,000 in investor loans, supporting critical-path activities.
- The Appendix 4C Cash Flow Report for January 2026 shows a net cash decrease from operating activities and net cash inflows from financing activities.
- Papyrus has secured a loan facility for $750,000, with $500,000 drawn down, and maintains a strong pathway towards commercialization and leadership in sustainable fibre products.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Camplify Holdings Limited (CHL) ORDINARY FULLY PAID |
Industrials |
$28 |
Change of Director's Interest Notice
|
27 Feb 2026 3:43PM |
$0.340 |
$0.340 |
fallen by
0%
|
|
| SOCO Corporation Ltd (SOC) ORDINARY FULLY PAID |
Information Technology |
$8 |
1H FY26 Results Announcement
|
27 Feb 2026 3:43PM |
$0.056 |
$0.056 |
fallen by
0%
|
|
SOC - Price-sensitive ASX Announcement
Full Release
Key Points
- Consolidated revenue decreased by 12% to $9.7 million.
- Core business revenue increased by 8.2% to $6.6 million.
- Axsym revenue decreased by 39% due to project delays.
- Restructuring reduced the cost base and improved sales capacity.
- Strongest first-half contracted sales on record.
- Gross margin decreased to 20.1%, but underlying services margin steady at 28.3%.
- Underlying EBITDA was ($0.6m); statutory NPAT was ($5.9m).
- Non-cash goodwill impairment of $4.6m related to Axsym.
- No further earn-out payment required for Axsym acquisition.
- Strategic repositioning to increase recurring revenue and improve visibility.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cauldron Energy Limited (CXU) ORDINARY FULLY PAID |
Energy |
$67 |
Half Yearly Report and Accounts
|
27 Feb 2026 3:43PM |
$0.031 |
$0.033 |
risen by
8.20%
|
|
| Hubify Limited (HFY) ORDINARY FULLY PAID |
Communication Services |
$11 |
Application for quotation of securities - HFY
|
27 Feb 2026 3:42PM |
$0.023 |
$0.021 |
fallen by
8.70%
|
|